Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00081367 · ClinicalTrials.gov registry record · Phase 3
Community-Based Cognitive Therapy for Suicide Attempters
A Phase 3 study of Suicide, Attempted, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 3
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT00081367: Completed Phase 3 study of Suicide, Attempted, sponsored by University of Pennsylvania.
NCT00081367 is a Phase 3 study of Suicide, Attempted that has completed, run by University of Pennsylvania. The registered enrollment target is 140 participants, below the 376-participant average among 36 other Suicide, Attempted trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00081367, a Phase 3 study of Suicide, Attempted, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine the effectiveness of cognitive behavioral therapy (CBT) in preventing future suicide attempts in repeat suicide attempters.
Conditions Studied
Interventions
- BEHAVIORAL CBT
- BEHAVIORAL Standard care alone
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2004-02 |
| Est. Completion | 2009-11 |
| Phase | Phase 3 |
What the finished NCT00081367 record still lists
NCT00081367 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 376-participant average among 36 other Suicide, Attempted trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Suicide, Attempted appearing as the primary indexed condition, and to 2 interventions - of which CBT is the first listed.
NCT00081367 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00081367 about?
NCT00081367 is a clinical study titled "Community-Based Cognitive Therapy for Suicide Attempters". This study will determine the effectiveness of cognitive behavioral therapy (CBT) in preventing future suicide attempts in repeat suicide attempters.
What is the current status of trial NCT00081367?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 140 participants. The study started on 2004-02. Estimated completion is 2009-11.
What conditions does trial NCT00081367 study?
This clinical trial studies the following conditions: Suicide, Attempted.
What interventions are being tested in trial NCT00081367?
The interventions under investigation include: CBT (BEHAVIORAL), Standard care alone (BEHAVIORAL).
Who is sponsoring clinical trial NCT00081367?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00081367 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide, Attempted
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00081367's enrollment target sits among peer trials
140 22nd of 36 higher than 15 of 36 other Suicide, Attempted trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide, Attempted trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketamine Treatment of Youth Suicide Attempters
RECRUITING · Phase 3
-
Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents
COMPLETED · Phase 3
-
Virtual Reality Lethal Means Safety Training
RECRUITING · NA
-
Skills to Enhance Positivity in Suicidal Youth
RECRUITING · NA
-
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia